Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pao Group Inc (OP: PAOG )

0.0036 USD +0.0001 (+2.86%)
Official Closing Price Updated: 3:55 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,381,002
Open 0.0035
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0035
Today's Range 0.0035 - 0.0039
52wk Range 0.0003 - 0.0059
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
PAOG Sets 2021 Cannabis Biopharmaceutical Revenue Goals
PAO Group, Inc. (USOTC: PAOG) today published a management outlook for 2021 on the company's strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included... 
From PR Newswire
PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment
PAO Group, Inc. (USOTC: PAOG) today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts. PAOG has engaged Veristat to assist in... 
From PR Newswire

Performance

YTD
+71.43%
+71.43%
1 Month
+63.64%
+63.64%
3 Month
+125.00%
+125.00%
6 Month
+33.33%
+33.33%
1 Year
+1100.00%
+1100.00%

More News

Read More
PURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis Market
Tags OTC Stocks Small Business Beverage
From OTC
PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Tags Medical Small Caps Consumer
From OTC
PAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product Line
From PR Newswire
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
Tags RespRx OTC Social Media
From OTC
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Tags Marijuana OTC RespRx
From OTC
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020
Tags OTC Markets Investment KALY
From OTC
PAOG Confirms Q4 2020 Revenue From Cannabis Asset Acquisition
Tags biotechnology ECommerce KALY
From OTC
PAOG Takes Major CBD Pharmaceutical Development Step Forward
Tags RespRx OTC Marijuana
From OTC
PAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend Distribution
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.